Kevin Auton was trained as a biochemist in protein research and cell culture at Southampton University supervised by Prof Chris Anthony and received a Ph.D for his research in protein expression analysis and characterisation. Subsequently, his entire career has been in the field of product development, manufacturing, sales and marketing for life science technology companies.
Dr Auton has been the inspiration and driving force behind the development of a succession of new products. During his career, he has led the development of 9 new products from first concepts through to prototype, into manufacture, marketing launch and closed sales to end users. Dr Auton founded Cellexus Biosystems in 2006 and is the inventor of the patented CellMaker technology. He also founded NextGen Sciences in 2000 with David Wigley, NextGen Sciences was awarded the Frost and Sullivan Technology Leadership Award for one if its products developed under Dr Auton’s leadership.
Most recently, Dr Auton has founded Aseptika - a fund raising consultancy which is now also developing a rapid diagnostic device to help those with cystic fibrosis stay well and Activ8rlives.com - a community-based website to enable ordinary people to keep healthy and stay well by working in groups.
Industry Expertise (3)
Southampton University: BSc PhD, Biochemistry 1988
- Aseptika and Activ8rlives.com
- Workshop Leader